CYP3A4*1G Genetic Polymorphism Influences Metabolism of Fentanyl in Human Liver Microsomes in Chinese Patients

By  

Pharmacology, Vol. 96, Iss. 1-2, 2015-06 ,pp. : 55-60

Karger

Access to resources Recommend Favorite

Effects of Silibinin, Inhibitor of CYP3A4 and P-Glycoprotein in vitro, on the Pharmacokinetics of Paclitaxel after Oral and Intravenous Administration in Rats

By  

Pharmacology, Vol. 85, Iss. 6, 2010-06 ,pp. : 350-356

Karger

Access to resources Recommend Favorite

The Influence of MDR1 G2677T/A Genetic Polymorphisms on the Pharmacokinetics of Repaglinide in Healthy Chinese Volunteers

By  

Pharmacology, Vol. 89, Iss. 1-2, 2012-03 ,pp. : 105-110

Karger

Access to resources Recommend Favorite

The Effects of H₂S on the Activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in Vivo in Rat

By Wang Xianqin   Han Anyue   Wen Congcong   Chen Mengchun   Chen Xinxin   Yang Xuezhi   Ma Jianshe   Lin Guanyang  

International Journal of Molecular Sciences, Vol. 14, Iss. 12, 2013-12 ,pp. : 24055-24063

MDPI

Access to resources Recommend Favorite

Effects of HMG-CoA Reductase Inhibitors on the Pharmacokinetics of Losartan and Its Main Metabolite EXP-3174 in Rats: Possible Role of CYP3A4 and P-gp Inhibition by HMG-CoA Reductase Inhibitors

By  

Pharmacology, Vol. 88, Iss. 1-2, 2011-06 ,pp. : 1-9

Karger

Access to resources Recommend Favorite